IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $73,302,299 | 9.86% |
| MPM BioImpact LLC | 2,614,977 | $15,977,509 | 4.15% |
| Perceptive Advisors | 15,339,735 | $93,725,780 | 2.77% |
| Ghost Tree Capital, LLC | 1,000,000 | $6,110,000 | 1.81% |
| Kynam Capital Management, LP | 1,800,000 | $10,998,000 | 1.42% |
| Velan Capital Investment Management LP | 220,000 | $1,344,200 | 1.15% |
| Boxer Capital, LLC | 3,705,133 | $22,638 | 1.11% |
| Soleus Capital Management, L.P. | 1,449,777 | $8,858,137 | 0.92% |
| Opaleye Management Inc. | 421,000 | $2,572,310 | 0.77% |
| Long Focus Capital Management, LLC | 2,061,814 | $12,597,684 | 0.71% |
| ACUTA CAPITAL PARTNERS, LLC | 153,639 | $938,734 | 0.69% |
| Avoro Capital Advisors LLC | 7,020,000 | $42,892,200 | 0.64% |
| 683 Capital Management, LLC | 1,325,000 | $8,095,750 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,729,964 | $10,570,080 | 0.60% |
| Orbimed Advisors | 4,707,458 | $28,762,568 | 0.56% |
| Parametrica Management Ltd | 48,700 | $297,557 | 0.54% |
| Rhenman & Partners Asset Management AB | 686,170 | $4,219,946 | 0.46% |
| Aristotle Atlantic Partners, LLC | 1,016,773 | $6,212,483 | 0.32% |
| Lombard Odier Asset Management (Switzerland) SA | 530,452 | $3,241,062 | 0.28% |
| Vivo Capital, LLC | 655,057 | $4,002,398 | 0.28% |
External links
This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q1 2023. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.